Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells

It has been previously demonstrated that genistein exhibits anticancer activity against breast cancer. However, the precise mechanisms underlying the anticancer effect of genistein, in particular the epigenetic basis, remain unclear. In this study, we investigated whether genistein could modulate the DNA methylation status and expression of cancer‐related genes in breast cancer cells. We treated MCF‐7 and MDA‐MB‐231 human breast cancer cells with genistein in vitro. We found that genistein decreased the levels of global DNA methylation, DNA methyltransferase (DNMT) activity and expression of DNMT1. Yet, the expression of DNMT3A and DNMT3B showed no significant change. Using molecular modeling, we observed that genistein might directly interact with the catalytic domain of DNMT1, thus competitively inhibiting the binding of hemimethylated DNA to the catalytic domain of DNMT1. Furthermore, genistein decreased DNA methylation in the promoter region of multiple tumor suppressor genes (TSGs) such as ataxia telangiectasia mutated (ATM), adenomatous polyposis coli (APC), phosphatase and tensin homolog (PTEN), mammary serpin peptidase inhibitor (SERPINB5), and increased the mRNA expression of these genes. However, we detected no significant changes in the DNA methylation status or mRNA expression of stratifin (SFN). These results suggest that the anticancer effect of genistein on breast cancer may be partly due to its ability to demethylate and reactivate methylation‐silenced TSGs through direct interaction with the DNMT1 catalytic domain and inhibition of DNMT1 expression. © 2014 Wiley Periodicals, Inc.

[1]  D. Ginzinger,et al.  The ATM gene is a target for epigenetic silencing in locally advanced breast cancer , 2004, Oncogene.

[2]  Ni Ai,et al.  Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. , 2003, Cancer research.

[3]  Zhiwei Wang,et al.  Multi-targeted therapy of cancer by genistein. , 2008, Cancer letters.

[4]  T. Tollefsbol,et al.  Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines , 2010, PloS one.

[5]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[6]  Y. Bignon,et al.  Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? , 2012, Omics : a journal of integrative biology.

[7]  M. Mi,et al.  MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis , 2012, Breast Cancer Research.

[8]  Yu Qin,et al.  Isoflavone consumption and risk of breast cancer: a dose-response meta-analysis of observational studies. , 2013, Asia Pacific journal of clinical nutrition.

[9]  R. Dahiya,et al.  Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B‐Cell translocation gene 3 in prostate cancer , 2009, Cancer.

[10]  Pang-Kuo Lo,et al.  Epigenomics and breast cancer. , 2008, Pharmacogenomics.

[11]  J. Christman,et al.  5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy , 2002, Oncogene.

[12]  J. Medina-Franco,et al.  Advances in the computational development of DNA methyltransferase inhibitors. , 2011, Drug discovery today.

[13]  T. Pandita,et al.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[15]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[17]  M. Mi,et al.  Flavonoids, Flavonoid Subclasses and Breast Cancer Risk: A Meta-Analysis of Epidemiologic Studies , 2013, PloS one.

[18]  J. Issa.  Cancer Prevention: Epigenetics Steps Up to the Plate , 2008, Cancer Prevention Research.

[19]  Phillip Koeffler,et al.  Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation , 2010, BMC Cancer.

[20]  T. Tollefsbol,et al.  Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. , 2010, Current medicinal chemistry.

[21]  Robert A. Waterland,et al.  Transposable Elements: Targets for Early Nutritional Effects on Epigenetic Gene Regulation , 2003, Molecular and Cellular Biology.

[22]  Peter A. Jones.  DNA methylation and cancer , 2002, Oncogene.

[23]  M. Robert,et al.  DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.

[24]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[25]  Kornelia Polyak,et al.  Breast cancer: origins and evolution. , 2007, The Journal of clinical investigation.

[26]  L. Howells,et al.  Differences between human breast cell lines in susceptibility towards growth inhibition by genistein , 2001, British Journal of Cancer.

[27]  M. Fang,et al.  Dietary polyphenols may affect DNA methylation. , 2007, The Journal of nutrition.

[28]  J. Hodges,et al.  Maternal diet supplementation with methyl donors and increased parity affect the incidence of craniofacial defects in the offspring of twisted gastrulation mutant mice. , 2013, The Journal of nutrition.

[29]  C. Atalay.  Epigenetics in breast cancer. , 2013, Experimental oncology.

[30]  Y. Bignon,et al.  DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines. , 2011, Epigenomics.

[31]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[32]  Katarzyna Lubecka-Pietruszewska,et al.  Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. , 2013, Biochemical and biophysical research communications.

[33]  C. Klein,et al.  Modulation of gene methylation by genistein or lycopene in breast cancer cells , 2008, Environmental and molecular mutagenesis.

[34]  Yi Sun,et al.  Reversal of Hypermethylation and Reactivation of p16INK4a, RARβ, and MGMT Genes by Genistein and Other Isoflavones from Soy , 2005, Clinical Cancer Research.

[35]  Ralf Schirrmacher,et al.  Establishment and functional validation of a structural homology model for human DNA methyltransferase 1. , 2003, Biochemical and biophysical research communications.

[36]  T. Tollefsbol,et al.  Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms , 2009, International journal of cancer.

[37]  Li Mao,et al.  Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  M. Fraga,et al.  Epigenetics and the environment: emerging patterns and implications , 2012, Nature Reviews Genetics.

[39]  J. Herman,et al.  Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. , 2000, Cancer research.

[40]  S. Bao,et al.  Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways , 2009, Cell biology international.

[41]  A. Toland,et al.  Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment. , 2009, Seminars in cancer biology.

[42]  A. Goel,et al.  Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. , 2010, Biochemical pharmacology.

[43]  R. Zoeller,et al.  Molecular basis of the anti-cancer effects of genistein isoflavone in LNCaP prostate cancer cells , 2011 .

[44]  Mariano Provencio,et al.  Promoter methylation of the PTEN gene is a common molecular change in breast cancer , 2004, Genes, chromosomes & cancer.